rise. a strategic victory for ukraine and its war with russia. retaking a key city and a territory. this as a putin ally urges him to take more drastic measures in the fight. and portland oregon homeless crisis, no laughing matter. she confronted him about it at a city council meeting. much more on this ahead. we began with fox team coverage. steve harrigan kicks things off for us tonight. steve. we have been going up and down the coast along highway 75 seeing these flooded communities. we are about to see how this dodge ram doesn t this water. this worker checking on some downed lines. before they could turn the power back on here. 700,000 people. they will be back at 95% of the people with power. we have remarkable drone footage as well. it shows the flooding in these neighborhoods. two-3 feet of water around many houses. cut off from the rest of the place. we have seen a lot of rescues yesterday. today we have been seeing more salvage. people going in and trying to get
share 20 transcripts from his witnesses with justice department investigators. the committee also seems to be zeroing in on former trump cabinet officials. of particular interest, conversations among those officials about possibly invoking the 25th amendment to remove trump from office. joining us now is johnwood, a former senior investigator for the january 6th select committee. he is running as an independent in missouri for the senate there. john, thank you so much for being with us. so, it was cnn s exclusive reporting, the department of justice is preparing to make a case to get around executive privilege, to basically force the testimony, to be prepared to force the testimony of key trump advisers. what does this tell you about where they are? where this federal investigation is? yeah, this is a really big step. up until a few days ago, there were very few public signs that the justice department was really focused on people in trump s immediate inner circle, as opp
ROCKLAND, Mass., October 10, 2023 EMD Serono, the Healthcare business sector of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the presentation of new analyses from the MAVENCLAD® (cladribine) tablets MAGNIFY-MS study, which demonstrated that patients with relapsing multiple sclerosis (RMS) experienced sustained reduction in serum neurofilament light chain (NfL), indicating that MAVENCLAD reduced neuronal injury over two years. Additional data include two real-world evi
The FDA is expected to approve a new pill for postpartum depression, Zuranolone. The pill got rid of PPD symptoms for a struggling new mom in a clinical trial.